Skip to main content
Equibles
BCAX logo

BCAX · Bicara Therapeutics Inc. · Webcasts, Transcripts & Audio

Track BCAX — free

Use BCAX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BCAX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.35 +0.88 (+5.04%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.22B
Shares
66.17M
Volume · Oct 20 488.5K Avg daily vol (3M) 671.3K

Bicara Therapeutics Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Bicara Therapeutics Inc. (BCAX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Conference
Investor event
2026-11-11
Bicara Therapeutics Inc. (BCAX) November 11, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-10
Bicara Therapeutics Inc. (BCAX) November 10, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-11
Bicara Therapeutics Inc. (BCAX) Q2 2026 Earnings Call Transcript
Confident tone Pivotal Phase III FORTIFY-HN01 study Commercial readiness and launch preparation Colorectal cancer signal-seeking study
Diluted EPS
$-0.82
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-05-13
Bicara Therapeutics Inc. (BCAX) May 13, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-11
Bicara Therapeutics Inc. (BCAX) Q1 2026 Earnings Call Transcript
Confident tone Clinical data and ASCO presentation Competitive landscape dynamics Leadership transition (CMO change)
Diluted EPS
$-0.93
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-30
Bicara Therapeutics Inc. (BCAX) Q4 2025 Earnings Call Transcript
Confident tone Breakthrough Therapy Designation and regulatory momentum Clinical data – durability and depth of response Interim analysis and overall survival endpoint
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Bicara Therapeutics Inc. (BCAX) Q3 2025 Earnings Call
Diluted EPS
$-0.67
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Bicara Therapeutics Inc. (BCAX) Q2 2025 Earnings Call
Diluted EPS
$-0.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Bicara Therapeutics Inc. (BCAX) Q1 2025 Earnings Call
Diluted EPS
$-0.68
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
Bicara Therapeutics Inc. (BCAX) Q4 2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Bicara Therapeutics Inc. (BCAX) Q3 2024 Earnings Call
Diluted EPS
$-1.60
Audio Transcript Slides 8-K10-Q
Showing 1–11 of 11 webcasts
Key facts CIK 2023658 CUSIP 055477103 13F (30d) 9 filings 9 filers Visit website Investor relations